Logo: Gib AIDS keine Chance - Die deutsche Antwort auf AIDS/HIV

Robert Koch InstituteRKI, Documents | Gib AIDS keine Chance - Die deutsche Antwort auf AIDS/HIV

Skip navigation
 
End of navigation

Robert Koch Institute
RKI

The Robert Koch Institute (RKI) is the central federal institution responsible for disease control and prevention in Germany. The RKI is the central federal reference institution for both applied and response-orientated research as well as for the Public Health Sector.

The tasks of the Robert Koch Institute comprise:

  • The identification of important health problems and associated scientific issues;
  • Applied and response-orientated research to resolve these issues;
  • The assessment of scientific results through analysis of current international developments in the respective scientific areas;
  • Informing and advising of political decision makers and the scientific sector;
  • Executive tasks defined by special laws, in particular with regard to protection from infection, legislation on stem cell research, and attacks using biological agents; and
  • The topical realization and coordination of federal health reporting.

In Germany anonymous reporting of newly diagnosed HIV infections is mandatory. The RKI is in charge of the national surveillance of HIV/AIDS and STIs including estimation of incidence and prevalence. RKI also conducts a series of epidemiological research projects, including clinical and virological surveillance, incidence research projects and participates in pathogenesis research. In the past years more research projects focusing on KABP (knowledge, attitude, behaviour and practices in sub-groups (e.g. MSM, drug users or sex workers) have been implemented at the institute.

At the European level the RKI is involved in a number of HIV related research networks such as

Documents

Basic HIV/AIDS Data and Trends for Germany

Basic HIV/AIDS data and trends in Germany (end of 2011)
Short epidemiological information of Robert Koch Institute (RKI)

HIV Cohort Studies at RKI

Increase of HIV-1 non-B subtype infections in men who have sex with men in Germany
Poster

Stable transmission rate of resistant HIV in Germany despite the introduction of new drugs in combination antiretroviral therapy
Poster

Increase of the prevalence of HIV-1 non-B subtypes in Germany – Results from the HIV-1 seroconverter study
Poster

Surveillance of transmitted HIV-1 drug resistance in the German HIV-1 seroconverter cohort from 1996 to 2010
Abstract

Calculation of direct antiretroviral treatment costs and potential cost savings by using generics in the German HIV ClinSurv cohort
published in: PLoS ONE, September 2011, Volume 6, Issue 9

Impact of transmitted drug resistance,TDR, on first line treatment success. Up-date of results of the German HIV-1 seroconverter cohort 2007 to 2010
Abstract

German Incidence Study

Recent HIV infections in men having sex with men in Germany – Results from the German HIV incidence study
Poster

The German HIV incidence study 2008-2010 – Recent infections by sociodemographic factors and mode of transmission
Poster

Recently acquired HIV infections in persons from high prevalence countries – Results from the HIV incidence study in Germany
Poster

“Let’s Talk about Sex!” – Differences in reported risk behaviour between recently HIV infected men having sex with men and HIV negative controls
Poster

Trends in recent infections among HIV-diagnoses from 2008-2011 using TRI. Results from two studies utilizing the BED-ELISA for incidence testing
Abstract

Other

STI rates and risk factors among female sex workers attending STI testing sites in Germany
Poster

European MSM Internet Survey (EMIS)
Abstract

Substance Use: Social, Behavioural and Cultural Issues. Drug and alcohol use, social and psycho‐social issues and related risk practices
Abstract

BORDERNETwork – STI Sentinel Surveillance in Bulgaria, Romania, Austria and the Slovak Republic
Presentation

Adobe Reader is needed to view the documents.